英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
sterlet查看　sterlet　在百度字典中的解释百度英翻中〔查看〕
sterlet查看　sterlet　在Google字典中的解释Google英翻中〔查看〕
sterlet查看　sterlet　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • SLAM Biotherapeutics
    SLAM BioTherapeutics is a next-generation oncology company advancing a platform of first-in-class antibody-drug conjugates (ADCs) and bispecifics that target the signaling lymphocytic activation molecule (SLAM) family of immune receptors
  • SLAM BioTherapeutics - BIO International Convention 2025
    SLAM Bio is an oncology biotech company developing a platform of first-in-class antibodies and ADCs against signaling lymphocytic activation molecule (SLAM) protein family
  • SLAM BioTherapeutics 2025 Company Profile: Valuation, Funding . . .
    Developer of oncology and autoimmune therapies intended to provide monoclonal antibodies for cancer and autoimmune diseases
  • SLAM Biotherapeutics- Force Family Office
    SLAM Biotherapeutics is an oncology biotech company developing first-in-class antibodies and antibody drug conjugates (ADCs) that meet this challenge with strong efficacy and a safe tox profile Their breakthrough antibodies will impact the lives of patients with life-threatening cancers
  • SLAM BioTherapeutics - LinkedIn
    SLAM BioTherapeutics | 242 followers on LinkedIn Biopharmaceutical focused on antibody therapies for Immuno Oncology (IO) segment Lead indications are TNBC and R R AML
  • SLAM Bio Appoints Chan Whiting, PhD, as Chief Scientific Officer to . . .
    SLAM BioTherapeutics is a next-generation oncology company advancing a platform of first-in-class antibody-drug conjugates (ADCs) and bispecifics that target the signaling lymphocytic activation molecule (SLAM) family of immune receptors
  • SLAM Biotherapeutics - 2025 Company Profile - Tracxn
    SLAM Biotherapeutics - Developer of immunotherapeutics for cancer treatment Raised a total funding of $8 2M over 2 rounds from 1 investor SLAM Biotherapeutics has 704 competitors
  • SLAM BioTherapeutics, a promising biotechnology company
    The company is targeting the signaling lymphocytic activation molecule (SLAM) family of receptors, which modulate myeloid-derived suppressor cells (MDSCs), B regulatory and T regulatory cells and associated activation of cytotoxic T and Natural Killer cells
  • The Future of Biotech: Steve Potts on Innovation, Policy, and the . . .
    The company is a preclinical-stage biotech company developing first-in-class monoclonal antibody therapies for cancer and autoimmune diseases SLAM Bio’s lead assets have first-in-class potential and demonstrate a profound effect on the tumor microenvironment in preclinical models
  • Slam Biotherapeutics, Inc. Company Profile - Dun Bradstreet
    Find company research, competitor information, contact details financial data for Slam Biotherapeutics, Inc of Thousand Oaks, CA Get the latest business insights from Dun Bradstreet





中文字典-英文字典  2005-2009